{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:38:16Z","timestamp":1786790296871,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02763"],"award-info":[{"award-number":["18H02763"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12149-018-1297-1","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:29:21Z","timestamp":1538382561000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Mahmudur G. M.","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-3383","authenticated-orcid":false,"given":"Hidehiko","family":"Okazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HT Benamer","year":"2000","unstructured":"Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson\u2019s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692\u20138.","journal-title":"Mov Disord"},{"key":"1297_CR2","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/mds.21710","volume":"22","author":"E Tolosa","year":"2007","unstructured":"Tolosa E, Borght TV, Moreno E. Accuracy of DaTSCAN (123I-ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord. 2007;22:2346\u201351.","journal-title":"Mov Disord"},{"key":"1297_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","volume":"81","author":"G K\u00e4gi","year":"2010","unstructured":"K\u00e4gi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81:5\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1297_CR4","doi-asserted-by":"publisher","first-page":"e0134457","DOI":"10.1371\/journal.pone.0134457","volume":"10","author":"MF Covington","year":"2015","unstructured":"Covington MF, Sherman S, Lewis D, Lei H, Krupinski E, Kuo PH. Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging. PLoS One. 2015;10(7):e0134457.","journal-title":"PLoS One"},{"key":"1297_CR5","first-page":"1109","volume":"46","author":"W Koch","year":"2005","unstructured":"Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer independent evaluation of dopamine transporter SPECT studies. J Nucl Med. 2005;46:1109\u201318.","journal-title":"J Nucl Med"},{"key":"1297_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/00006231-200106000-00017","volume":"22","author":"M Chouker","year":"2001","unstructured":"Chouker M, Tatsch K, Linke R, Pogarell O, Hahn K, Schwarz J. Striatal dopamine transporter binding in early to moderate advanced Parkinson\u2019s disease: monitoring of disease progression over 2 years. Nucl Med Commun. 2001;22:721\u20135.","journal-title":"Nucl Med Commun"},{"key":"1297_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s002590000460","volume":"28","author":"J Booij","year":"2001","unstructured":"Booij J, Speelman JD, Horstink MWIM, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FPCIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266\u201372.","journal-title":"Eur J Nucl Med"},{"key":"1297_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","volume":"287","author":"Parkinson Study Group","year":"2002","unstructured":"Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA. 2002;287:1653\u201361.","journal-title":"JAMA"},{"key":"1297_CR9","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s00259-006-0357-2","volume":"34","author":"P Calvini","year":"2007","unstructured":"Calvini P, Rodriguez G, Inguglia F, Mignone A, Guerra UP, Nobili F. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging. 2007;34:1240\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00259-012-2304-8","volume":"40","author":"F Nobili","year":"2013","unstructured":"Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 2013;40:565\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR11","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","volume":"33","author":"L Tossici-Bolt","year":"2006","unstructured":"Tossici-Bolt L, Hoffmann S, Kemp P, Mehta R, Fleming J. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med. 2006;33:1491\u20139.","journal-title":"Eur J Nucl Med"},{"key":"1297_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000479627","volume":"78","author":"H Neishi","year":"2017","unstructured":"Neishi H, Ikawa M, Okazawa H, Tsujikawa T, Arishima H, Kikuta K, Yoneda M. Precise evaluation of striatal oxidative stress corrected for severity of dopaminergic neuronal degeneration in patients with Parkinson\u2019s disease: a study with 62Cu-ATSM PET and 123I-FP-CIT SPECT. Eur Neurol. 2017;78:161\u20138.","journal-title":"Eur Neurol"},{"key":"1297_CR13","first-page":"166","volume-title":"The human brain in figures and tables. A quantitative handbook","author":"SM Blinkov","year":"1968","unstructured":"Blinkov SM, Glezer II. The human brain in figures and tables. A quantitative handbook. New York: Basic Books; 1968. pp.\u00a0166\u201371."},{"key":"1297_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0925-4927(97)00011-5","volume":"74","author":"EH Aylward","year":"1997","unstructured":"Aylward EH, Li Q, Habbak R, Warren A, Pulsifer MB, Barta PE, Jerram M, Pearlson G. Basal ganglia volume in adults with Down syndrome. Psychiatry Res. 1997;74:73\u201382.","journal-title":"Psychiatry Res"},{"key":"1297_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp-2011-301695","volume":"83","author":"AR Kupsch","year":"2012","unstructured":"Kupsch AR, Bajaj N, Weiland F, et al. Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. J Neurol Neurosurg Psychiat. 2012;83:620\u201328.","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"1297_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2967\/jnumed.111.100784","volume":"53","author":"DS Djang","year":"2012","unstructured":"Djang DS, Janssen MJ, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012;53:154\u201363.","journal-title":"J Nucl Med"},{"key":"1297_CR18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00259-011-1801-5","volume":"38","author":"L Tossici-Bolt","year":"2011","unstructured":"Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara MC, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011;38:1529\u201340.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00259-016-3309-5","volume":"43","author":"R Buchert","year":"2016","unstructured":"Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, et al. Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging. 2016;43:1323\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12149-016-1107-6","volume":"30","author":"M Nonokuma","year":"2016","unstructured":"Nonokuma M, Kuwabara Y, Hida K, Tani T, Takano K, Yoshimitsu K. Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT. Ann Nucl Med. 2016;30:637\u201344.","journal-title":"Ann Nucl Med"},{"key":"1297_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12149-018-1249-9","volume":"32","author":"S Mizumura","year":"2018","unstructured":"Mizumura S, Nishikawa K, Murata A, Yoshimura K, Ishii N, Kokubo T, et al. Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count. Ann Nucl Med. 2018;32:288\u201396.","journal-title":"Ann Nucl Med"},{"key":"1297_CR22","first-page":"130","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, et al. CLE differentiation of dementia with lewy bodies from Alzheimer\u2019s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73:130\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1297_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AGM, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;62:133\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1297_CR24","first-page":"1879","volume":"39","author":"J Booij","year":"1998","unstructured":"Booij J, Habraken JBA, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Imaging of dopamine transporter with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson\u2019s disease. J Nucl Med. 1998;39:1879\u201384.","journal-title":"J Nucl Med"},{"key":"1297_CR25","first-page":"1500","volume":"39","author":"JP Seibyl","year":"1998","unstructured":"Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RB, Charney DS, et al. Iodine-123-\u03b2-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporter in healthy subjects and Parkinson\u2019s patients. J Nucl Med. 1998;39:1500\u20138.","journal-title":"J Nucl Med"},{"key":"1297_CR26","first-page":"1175","volume":"36","author":"CH van Dyck","year":"1995","unstructured":"van Dyck CH, Seibyl JP, Malison RT, Laurelle M, Wallace E, Zoghbi SS, et al. Age-related decline in striatal dopamine transporter binding with iodine-123-\u03b2-CIT SPECT. J Nucl Med. 1995;36:1175\u201381.","journal-title":"J Nucl Med"},{"key":"1297_CR27","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s00259-010-1664-1","volume":"38","author":"K Badiavas","year":"2011","unstructured":"Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N. SPECT imaging evaluation in movement disorders: far beyond visual assessment. Eur J Nucl Med Mol Imaging. 2011;38:764\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR28","first-page":"1511","volume":"39","author":"M Ichise","year":"1998","unstructured":"Ichise M, Ballinger JR, Tanaka F, Moscovitch M, St. George-Hyslop PH, Raphael D, et al. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med. 1998;39:1511\u20138.","journal-title":"J Nucl Med"},{"key":"1297_CR29","first-page":"1694","volume":"45","author":"J Schwarz","year":"2004","unstructured":"Schwarz J, Storch A, Koch W, Pogarelli O, Radau PE, Tatsch K. Loss of dopamine transporter binding follows a single exponential rather than linear decline. J Nucl Med. 2004;45:1694\u20137.","journal-title":"J Nucl Med"},{"key":"1297_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF02984583","volume":"18","author":"T Tsuchida","year":"2004","unstructured":"Tsuchida T, Ballinger JR, Vines D, Kim YJ, Utsunomiya K, Lang AE, et al. Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson\u2019s disease patients. Ann Nucl Med. 2004;18:609\u201316.","journal-title":"Ann Nucl Med"},{"key":"1297_CR31","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","volume":"15","author":"W Pirker","year":"2000","unstructured":"Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, et al. [123I]-\u03b2-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord. 2000;15:1158\u201367.","journal-title":"Mov Disord"},{"key":"1297_CR32","first-page":"36","volume":"41","author":"W Pirker","year":"2000","unstructured":"Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, et al. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med. 2000;41:36\u201344.","journal-title":"J Nucl Med"},{"key":"1297_CR33","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1007\/s00259-007-0711-z","volume":"35","author":"C Crespo","year":"2008","unstructured":"Crespo C, Gallego J, Cot A, Falc\u00f3n C, Bullich S, Pareto D, Aguiar P, Sempau J, Lome\u00f1a F, Calvi\u00f1o F, Pav\u00eda J, Ros D. Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation. Eur J Nucl Med Mol Imaging. 2008;35:1334\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1297_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3413\/Nukmed-0659-14-04","volume":"53","author":"D Kupitz","year":"2014","unstructured":"Kupitz D, Apostolova I, Lange C, Ulrich G, Amthauer H, Brenner W, et al. Global scaling for semi-quantitative analysis in FP-CIT SPECT. Nuklearmedizin. 2014;53:234\u201341.","journal-title":"Nuklearmedizin"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-018-1297-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:49:32Z","timestamp":1589449772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-018-1297-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s12149-018-1297-1","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}